HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keith D Kaufman Selected Research

Glipizide (Glucotrol)

5/2013Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency.
4/2013Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial.
8/2012Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value.
7/2011Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keith D Kaufman Research Topics

Disease

49Type 2 Diabetes Mellitus (MODY)
01/2022 - 02/2008
22Hypoglycemia (Reactive Hypoglycemia)
04/2018 - 02/2008
13Body Weight (Weight, Body)
11/2017 - 04/2007
8Alopecia (Baldness)
09/2012 - 01/2002
6Weight Loss (Weight Reduction)
10/2017 - 10/2006
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2013
4Stroke (Strokes)
12/2019 - 12/2013
4Myocardial Infarction
12/2019 - 12/2013
3Overweight
01/2022 - 10/2006
3Constipation
01/2021 - 04/2010
3Renal Insufficiency (Renal Failure)
10/2020 - 05/2013
3Heart Failure
11/2017 - 07/2015
3Weight Gain
10/2017 - 05/2013
3Diarrhea
01/2017 - 04/2010
2Hip Fractures (Intertrochanteric Fractures)
12/2019 - 01/2017
2Unstable Angina
04/2017 - 12/2013
2Pancreatitis
04/2017 - 01/2013
2Nausea
01/2017 - 04/2010
1Virilism (Virilization)
01/2022
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2022
1Back Pain (Backache)
01/2021
1Human Influenza (Influenza)
01/2021
1Nasopharyngitis
01/2021
1Arthralgia (Joint Pain)
01/2021
1Osteoporosis
12/2019
1Atrial Fibrillation
12/2019
1Postmenopausal Osteoporosis
12/2019
1Bone Resorption
12/2019
1Disease Progression
11/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2017
1Vomiting
01/2017
1Abdominal Pain (Pain, Abdominal)
01/2017
1Osteoporotic Fractures
01/2017
1Edema (Dropsy)
09/2016
1Chronic Renal Insufficiency
05/2013
1Cellulitis
04/2013
1Chronic Kidney Failure (Chronic Renal Failure)
04/2013
1Headache (Headaches)
04/2013
1Neoplasms (Cancer)
01/2013
1Flushing
04/2010
1Hypertriglyceridemia
01/2005
1Hypertension (High Blood Pressure)
01/2005
1Glucose Intolerance
01/2005
1Insulin Resistance
01/2005
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2005
1Dyslipidemias (Dyslipidemia)
01/2005
1Obesity
01/2005
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2003

Drug/Important Bio-Agent (IBA)

39Sitagliptin Phosphate (Januvia)FDA Link
01/2022 - 02/2008
19Metformin (Glucophage)FDA LinkGeneric
01/2022 - 02/2008
92- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
04/2018 - 11/2015
8Finasteride (Propecia)FDA LinkGeneric
09/2012 - 01/2002
7Dipeptidyl-Peptidase IV InhibitorsIBA
11/2017 - 03/2015
7Hypoglycemic Agents (Hypoglycemics)IBA
11/2017 - 10/2008
5Glucose (Dextrose)FDA LinkGeneric
12/2018 - 08/2012
4Pharmaceutical PreparationsIBA
01/2021 - 01/2005
4Glipizide (Glucotrol)FDA LinkGeneric
05/2013 - 07/2011
3Insulin (Novolin)FDA Link
01/2022 - 12/2011
3Insulin Glargine (Lantus)FDA Link
01/2019 - 12/2011
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2016 - 09/2013
3Hemoglobins (Hemoglobin)IBA
12/2013 - 03/2013
3trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA
08/2007 - 10/2006
2AutoantibodiesIBA
01/2022 - 01/2022
2ipragliflozinIBA
01/2021 - 01/2021
2dapagliflozinIBA
10/2020 - 12/2018
2glimepiride (Amarel)FDA LinkGeneric
11/2017 - 10/2017
2Pioglitazone (Actos)FDA Link
09/2016 - 03/2013
2N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA
12/2010 - 04/2010
2Neuropeptide YIBA
08/2007 - 04/2007
2neuropeptide Y5 receptorIBA
08/2007 - 10/2006
1Testosterone (Sustanon)FDA Link
01/2022
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2022
1human follicle stimulating hormone with HCG C-terminal peptideIBA
01/2022
1GonadotropinsIBA
01/2022
1Cathepsin KIBA
12/2019
1odanacatibIBA
12/2019
1SodiumIBA
12/2018
1omega-Chloroacetophenone (Mace)IBA
11/2017
1AcarboseFDA LinkGeneric
01/2017
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2015
1antineoplaston A10 (A 10)IBA
05/2013
1Rosiglitazone (Avandia)FDA Link
03/2013
13- ((6- (ethylsulfonyl)- 3- pyridinyl)oxy)- 5- (2- hydroxy- 1- methylethoxy)- N- (1- methyl- 1H- pyrazol- 3- yl)benzamideIBA
12/2011
1GlucokinaseIBA
12/2011
1Triglycerides (Triacylglycerol)IBA
12/2011
1Hemoglobin AIBA
02/2008
1Orlistat (Xenical)FDA Link
08/2007
1sibutramine (Meridia)FDA Link
08/2007
1Hormones (Hormone)IBA
08/2007
1HDL CholesterolIBA
01/2005
1LipidsIBA
01/2005
1Nonesterified Fatty Acids (NEFA)IBA
01/2005
1AndrogensIBA
12/2002
1Dihydrotestosterone (Androstanolone)IBA
04/2002

Therapy/Procedure

19Glycemic Control
01/2022 - 01/2009
17Therapeutics
01/2022 - 06/2003
2Caloric Restriction
12/2010 - 04/2007
2Aftercare (After-Treatment)
07/2006 - 04/2002
1Precision Medicine
01/2022
1Drug Therapy (Chemotherapy)
12/2010